 In patients with chronic chest pain with a high clinical probability of CAD or known ischemic heart disease (IHD), imaging is used to characterize known and unknown IHD. In patients with no known IHD, imaging is valuable in determining and documenting the presence, extent, and severity of obstructive coronary narrowing as well as the presence of myocardial ischemia. Imaging also allows for exclusion of nonocclusive atherosclerotic CAD and/or aHarvard Medical School, Boston, Massachusetts. bPanel Chair, Duke University Medical Center, Durham, North Carolina. cPanel Vice-Chair, Massachusetts General Hospital, Boston, Massachusetts. dUniversity of Michigan, Ann Arbor, Michigan. eUniversity of Virginia Health System, Charlottesville, Virginia; Nuclear cardiology expert. fUniversity of Michigan Health System, Ann Arbor, Michigan. gThe University of Chicago Medical Center, Chicago, Illinois; American College of Physicians. hOregon Health & Science University, Portland, Oregon. iQueen's University, Kingston, Ontario, Canada; Cardiology expert. jUniversity of California San Diego, San Diego, California. kVA Palo Alto Health Care System, Palo Alto, California and Stanford University, Stanford, California. lNaval Medical Center Portsmouth, Portsmouth, Virginia. mMassachusetts General Hospital, Boston, Massachusetts. nWake Forest University Health Sciences, Winston Salem, North Carolina; Society for Cardiovascular Magnetic Resonance. oUniversity of Virginia Health Center, Charlottesville, Virginia; Society of Cardiovascular Computed Tomography. pSpecialty Chair, UT Southwestern Medical Center, Dallas, Texas. The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through representation of such organizations on expert panels.
Chronic Chest Pain High Probability of Coronary Artery Disease PCAs.  In patients with chronic chest pain with a high clinical probability of CAD or known ischemic heart disease (IHD), imaging is used to characterize known and unknown IHD. In patients with no known IHD, imaging is valuable in determining and documenting the presence, extent, and severity of obstructive coronary narrowing as well as the presence of myocardial ischemia. Imaging also allows for exclusion of nonocclusive atherosclerotic CAD and/or aHarvard Medical School, Boston, Massachusetts. bPanel Chair, Duke University Medical Center, Durham, North Carolina. cPanel Vice-Chair, Massachusetts General Hospital, Boston, Massachusetts. dUniversity of Michigan, Ann Arbor, Michigan. eUniversity of Virginia Health System, Charlottesville, Virginia; Nuclear cardiology expert. fUniversity of Michigan Health System, Ann Arbor, Michigan. gThe University of Chicago Medical Center, Chicago, Illinois; American College of Physicians. hOregon Health & Science University, Portland, Oregon. iQueen's University, Kingston, Ontario, Canada; Cardiology expert. jUniversity of California San Diego, San Diego, California. kVA Palo Alto Health Care System, Palo Alto, California and Stanford University, Stanford, California. lNaval Medical Center Portsmouth, Portsmouth, Virginia. mMassachusetts General Hospital, Boston, Massachusetts. nWake Forest University Health Sciences, Winston Salem, North Carolina; Society for Cardiovascular Magnetic Resonance. oUniversity of Virginia Health Center, Charlottesville, Virginia; Society of Cardiovascular Computed Tomography. pSpecialty Chair, UT Southwestern Medical Center, Dallas, Texas. The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through representation of such organizations on expert panels.